BR112014024256A8 - Composição biorrelevante homogênea, meio biorrelevante aquoso, métodos de preparar um meio biorrelevante aquoso e uma composição homogênea, e, uso do meio biorrelevante aquoso - Google Patents
Composição biorrelevante homogênea, meio biorrelevante aquoso, métodos de preparar um meio biorrelevante aquoso e uma composição homogênea, e, uso do meio biorrelevante aquosoInfo
- Publication number
- BR112014024256A8 BR112014024256A8 BR112014024256A BR112014024256A BR112014024256A8 BR 112014024256 A8 BR112014024256 A8 BR 112014024256A8 BR 112014024256 A BR112014024256 A BR 112014024256A BR 112014024256 A BR112014024256 A BR 112014024256A BR 112014024256 A8 BR112014024256 A8 BR 112014024256A8
- Authority
- BR
- Brazil
- Prior art keywords
- biorelevant
- aqueous
- medium
- composition
- homogeneous
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 abstract 1
- 239000003833 bile salt Substances 0.000 abstract 1
- -1 fatty acid salt Chemical class 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 abstract 1
- 229940045946 sodium taurodeoxycholate Drugs 0.000 abstract 1
- YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
- G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Computational Mathematics (AREA)
- Educational Administration (AREA)
- Mathematical Analysis (AREA)
- Business, Economics & Management (AREA)
- Algebra (AREA)
- Pure & Applied Mathematics (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12162548.7A EP2645099A1 (en) | 2012-03-30 | 2012-03-30 | Biorelevant compositions |
| PCT/EP2013/056945 WO2013144374A1 (en) | 2012-03-30 | 2013-04-02 | Biorelevant compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014024256A2 BR112014024256A2 (https=) | 2017-06-20 |
| BR112014024256A8 true BR112014024256A8 (pt) | 2018-02-06 |
Family
ID=48143258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014024256A BR112014024256A8 (pt) | 2012-03-30 | 2013-04-02 | Composição biorrelevante homogênea, meio biorrelevante aquoso, métodos de preparar um meio biorrelevante aquoso e uma composição homogênea, e, uso do meio biorrelevante aquoso |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150064794A1 (https=) |
| EP (2) | EP2645099A1 (https=) |
| JP (1) | JP6348480B2 (https=) |
| KR (1) | KR20140144255A (https=) |
| CN (1) | CN104582689A (https=) |
| BR (1) | BR112014024256A8 (https=) |
| CA (1) | CA2867638A1 (https=) |
| IN (1) | IN2014DN07927A (https=) |
| MX (1) | MX357927B (https=) |
| NZ (1) | NZ700064A (https=) |
| WO (1) | WO2013144374A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102034606B1 (ko) * | 2011-08-23 | 2019-10-22 | 알레간 세일즈, 엘엘씨 | 데옥시콜린산 및 그의 염들의 제형물들 |
| WO2019199238A1 (en) * | 2018-04-09 | 2019-10-17 | Vet Products Research And Innovation Center Company Limited | Inorganic mineral entrapped in nanoparticle production method thereof |
| GB201809627D0 (en) * | 2018-06-12 | 2018-07-25 | Biorelevant Com Ltd | Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling |
| GB201904757D0 (en) * | 2019-04-04 | 2019-05-22 | Biorelevant Com Ltd | Biorelevant composition |
| CN114080539A (zh) * | 2019-06-28 | 2022-02-22 | 詹森药业有限公司 | 生物相关溶出介质 |
| WO2021165386A1 (de) | 2020-02-19 | 2021-08-26 | Bayer Aktiengesellschaft | Vorhersage von formulierungseigenschaften |
| GB202112975D0 (en) | 2021-09-10 | 2021-10-27 | Biorelevant Com Ltd | Biorelevant dissolution compositions with reproducible spectral profiles |
| GB202405714D0 (en) * | 2024-04-23 | 2024-06-05 | Biorelevant Com Ltd | Biorelevant compositions and media for in vitro testing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| GB8909022D0 (en) * | 1989-04-20 | 1989-06-07 | Cortecs Ltd | Pharmaceutical compositions |
| US6040188A (en) * | 1997-11-18 | 2000-03-21 | The Regents Of The University Of California | In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants |
| IT1296914B1 (it) * | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
| WO2003042392A1 (en) * | 2001-11-15 | 2003-05-22 | Phares Pharmaceutical Research N.V. | Standardised phospholipid mixtures |
| CA2560900A1 (en) * | 2004-03-26 | 2005-10-06 | Cell Therapeutics Europe S.R.L. | Nanoparticle formulations of platinum compounds |
| GB0522942D0 (en) * | 2005-11-10 | 2005-12-21 | Leigh Steven | Dissolution composition |
| WO2007085970A2 (en) * | 2006-01-27 | 2007-08-02 | Danisco A/S | Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
| WO2008040799A2 (en) | 2006-10-06 | 2008-04-10 | Boehringer Ingelheim International Gmbh | Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
-
2012
- 2012-03-30 EP EP12162548.7A patent/EP2645099A1/en not_active Ceased
-
2013
- 2013-04-02 CN CN201380018498.8A patent/CN104582689A/zh active Pending
- 2013-04-02 BR BR112014024256A patent/BR112014024256A8/pt not_active Application Discontinuation
- 2013-04-02 CA CA2867638A patent/CA2867638A1/en not_active Abandoned
- 2013-04-02 IN IN7927DEN2014 patent/IN2014DN07927A/en unknown
- 2013-04-02 EP EP13717734.1A patent/EP2830592A1/en not_active Withdrawn
- 2013-04-02 NZ NZ700064A patent/NZ700064A/en not_active IP Right Cessation
- 2013-04-02 JP JP2015502383A patent/JP6348480B2/ja not_active Expired - Fee Related
- 2013-04-02 US US14/389,701 patent/US20150064794A1/en not_active Abandoned
- 2013-04-02 MX MX2014011789A patent/MX357927B/es active IP Right Grant
- 2013-04-02 WO PCT/EP2013/056945 patent/WO2013144374A1/en not_active Ceased
- 2013-04-02 KR KR1020147030491A patent/KR20140144255A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NZ700064A (en) | 2016-08-26 |
| BR112014024256A2 (https=) | 2017-06-20 |
| IN2014DN07927A (https=) | 2015-05-01 |
| EP2645099A1 (en) | 2013-10-02 |
| CA2867638A1 (en) | 2013-10-03 |
| US20150064794A1 (en) | 2015-03-05 |
| MX2014011789A (es) | 2015-06-03 |
| JP2015524913A (ja) | 2015-08-27 |
| MX357927B (es) | 2018-07-27 |
| WO2013144374A1 (en) | 2013-10-03 |
| CN104582689A (zh) | 2015-04-29 |
| JP6348480B2 (ja) | 2018-06-27 |
| EP2830592A1 (en) | 2015-02-04 |
| KR20140144255A (ko) | 2014-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014024256A8 (pt) | Composição biorrelevante homogênea, meio biorrelevante aquoso, métodos de preparar um meio biorrelevante aquoso e uma composição homogênea, e, uso do meio biorrelevante aquoso | |
| Gong et al. | Cytotoxicity, oxidative stress and inflammation induced by ZnO nanoparticles in endothelial cells: interaction with palmitate or lipopolysaccharide | |
| BR112012011534A2 (pt) | materiais de liberação de blenda de fluorossilicone | |
| BR112012033735A2 (pt) | composição líquida, método de gravação, e matéria gravada | |
| BR112015017405A2 (pt) | composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas | |
| EA201270050A1 (ru) | Нанодисперсия лекарственного средства и способ ее получения | |
| Yin et al. | Effects of bile acids on growth performance and lipid metabolism during chronic heat stress in broiler chickens | |
| BR112015001620A2 (pt) | composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição | |
| IN2012DN00781A (https=) | ||
| FR2968951B1 (fr) | Composition cosmetique comprenant un compose d'acide cucurbique | |
| MX2012009088A (es) | Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos. | |
| BRPI0711932A8 (pt) | Uso de um polímero na transferência de uma suspensão do material mineral particulado | |
| BRPI0906478B8 (pt) | anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende | |
| BR112015005278A2 (pt) | composições e métodos para encapsulação dupla de composto volátil | |
| UY31073A1 (es) | Inhibidores de la proteína activadora de la 5-lipoxigenasa (flap) | |
| BR112013026982A2 (pt) | composição de combustível líquido, processos para preparar uma composição de combustível líquido e para operar um motor, e, uso da composição de combustível líquido | |
| BR112013027086A2 (pt) | composto, composição aquosa, composição de emulsão, composição bifásica, método de deslocamento de um material de hidrocarboneto em contato com um material sólido, método de conversão de um ácido de petróleo não refinado em um tensoativo e método de preparação de um composto | |
| WO2009143133A3 (en) | Compositions and methods to protect cells by blocking entry of pathogen proteins | |
| BR112013028760A2 (pt) | composição adjuvante e formulação agroquímica contendo a mesma | |
| BR112018068818A2 (pt) | composição de óleo combustível, processo para a sua preparação, método de alteração de grau de um óleo combustível líquido e método de ajuste do ponto de ignição do mesmo | |
| BR112012033806A2 (pt) | composição na forma de uma partícula, método para sua preparação e uso da composição | |
| BRPI0519118A2 (pt) | composiÇço particulada prontamente dispersÁvel em Água, dispersço aquosa de distintas partÍculas intumescidas, produto alimentÍcio, fluido de perfuraÇço, composiÇço farmacÊutica, e, processos para preparar uma soluÇço de goma xantana e para manufaturar uma composiÇço particulada prontamente dispersÁvel em Água | |
| TR200806590A2 (tr) | Tarım ilacı bileşimleri | |
| Hashem et al. | Mitigating the growth, biochemical changes, genotoxic and pathological effects of copper toxicity in broiler chickens by supplementing vitamins C and E | |
| Lv et al. | Sodium butyrate‐loaded microspheres with enhanced bioavailability for targeted treatment of intestinal barrier injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: BIORELEVANT.COM LTD (GB) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |